The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic ...

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

A new study points to a bacterial toxin as fueling a rise in early-onset colorectal cancer cases. But what is this toxin—and ...

Researchers at , Sweden, have discovered a previously unknown type of connective tissue cells that surround cancer cells in pancreatic tumors.

Scientists at Cincinnati Children's along with an international team of researchers have discovered a surprising new connection between gut health and blood cancer risk-one that could transform how we ...

T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited to the pancreas and size 2–4 cm T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor ...

The truth behind the rise in colon cancer and the signs to look for - If trends continue, colorectal cancer could become the leading cause of cancer-related death among young adults ...

Researchers found that the toxin’s negative effects begin in childhood. In other news, contrary to what has been said, the food industry says no agreement is in place with the HHS to remove artificial ...